Home CAMP4 Therapeutics

CAMP4 Therapeutics

In operation
Post-IPO Round
Developer of Programmable Treatment Methods
Basic
Enterprise Profile
LinkedIn

Basic Information

CAMP4 Therapeutics has pioneered a new programmable treatment method that combines a deep understanding of RNA and gene expression regulation with complementary and customizable oligonucleotide patterns. The proprietary insights of our RNA-driven platform enable us to harness the power of RNA to upregulate gene expression and unlock the potential to create treatments for hundreds of diseases affecting millions of patients.
CAMP4 Therapeutics Corporation
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2016
info@camp4tx.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Gene Technology Targeted Technology Cell Technology
Concept
Disease Treatment
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs